CN113698359B - Method for synthesizing 3,5-disubstituted isoxazole compound based on three-component reaction - Google Patents
Method for synthesizing 3,5-disubstituted isoxazole compound based on three-component reaction Download PDFInfo
- Publication number
- CN113698359B CN113698359B CN202110994157.0A CN202110994157A CN113698359B CN 113698359 B CN113698359 B CN 113698359B CN 202110994157 A CN202110994157 A CN 202110994157A CN 113698359 B CN113698359 B CN 113698359B
- Authority
- CN
- China
- Prior art keywords
- reaction
- synthesizing
- disubstituted
- component reaction
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- -1 3,5-disubstituted isoxazole compound Chemical class 0.000 title claims abstract description 43
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 30
- 238000010490 three component reaction Methods 0.000 title claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 58
- 150000001336 alkenes Chemical class 0.000 claims abstract description 14
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims abstract description 10
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims abstract description 8
- 230000002378 acidificating effect Effects 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 150000001299 aldehydes Chemical class 0.000 claims description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 6
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical group CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 claims description 6
- 239000012414 tert-butyl nitrite Substances 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 4
- 150000003934 aromatic aldehydes Chemical class 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 claims description 2
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical group NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical group COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 150000002826 nitrites Chemical class 0.000 claims description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 2
- 235000011009 potassium phosphates Nutrition 0.000 claims description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 2
- 239000001632 sodium acetate Substances 0.000 claims description 2
- 235000017281 sodium acetate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 claims description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000000758 substrate Substances 0.000 abstract description 15
- 239000002994 raw material Substances 0.000 abstract description 6
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 abstract description 2
- 239000011261 inert gas Substances 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 18
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 8
- 238000007363 ring formation reaction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000007366 cycloisomerization reaction Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000006482 condensation reaction Methods 0.000 description 5
- 150000002545 isoxazoles Chemical class 0.000 description 5
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 150000002923 oximes Chemical class 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- FZENGILVLUJGJX-NSCUHMNNSA-N (E)-acetaldehyde oxime Chemical compound C\C=N\O FZENGILVLUJGJX-NSCUHMNNSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001345 alkine derivatives Chemical class 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- HZVPJXOQDCOJRJ-UHFFFAOYSA-N isoxazolin-5-one Chemical compound O=C1C=CNO1 HZVPJXOQDCOJRJ-UHFFFAOYSA-N 0.000 description 3
- 125000000842 isoxazolyl group Chemical group 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- FUOSTELFLYZQCW-UHFFFAOYSA-N 1,2-oxazol-3-one Chemical compound OC=1C=CON=1 FUOSTELFLYZQCW-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- HECRDSFKLUVCAY-UHFFFAOYSA-N 3,5-diphenyl-1,2-oxazole Chemical compound C=1C(C=2C=CC=CC=2)=NOC=1C1=CC=CC=C1 HECRDSFKLUVCAY-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010958 [3+2] cycloaddition reaction Methods 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000006352 cycloaddition reaction Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- WGGLDBIZIQMEGH-UHFFFAOYSA-N 1-bromo-4-ethenylbenzene Chemical compound BrC1=CC=C(C=C)C=C1 WGGLDBIZIQMEGH-UHFFFAOYSA-N 0.000 description 1
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- JQJPBYFTQAANLE-UHFFFAOYSA-N Butyl nitrite Chemical compound CCCCON=O JQJPBYFTQAANLE-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- KVFDZFBHBWTVID-UHFFFAOYSA-N cyclohexanecarbaldehyde Chemical compound O=CC1CCCCC1 KVFDZFBHBWTVID-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- REVLCBCMFHHOGK-UHFFFAOYSA-N ethyl 4,5-dihydro-1,2-oxazole-3-carboxylate Chemical compound CCOC(=O)C1=NOCC1 REVLCBCMFHHOGK-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical class CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- APNSGVMLAYLYCT-UHFFFAOYSA-N isobutyl nitrite Chemical compound CC(C)CON=O APNSGVMLAYLYCT-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000010667 large scale reaction Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 1
- 229960001019 oxacillin Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 description 1
- 229960002004 valdecoxib Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
技术领域technical field
本发明属于有机合成技术领域,特别涉及一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法。The invention belongs to the technical field of organic synthesis, in particular to a method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction.
背景技术Background technique
早在1888年,Claisen等人采用β-酮酯和羟胺反应环化生成了3-羟基异恶唑。此后,大量学者通过[3+2]环加成反应,环化异构化反应,缩合反应等方式,不断丰富着异恶唑的合成方法学研究(图1所示)。现将异恶唑合成方法按类型分类后总结如下:As early as 1888, Claisen et al. used the cyclization reaction of β-ketoester and hydroxylamine to generate 3-hydroxyisoxazole. Since then, a large number of scholars have continuously enriched the research on the synthesis methodology of isoxazoles through [3+2] cycloaddition reactions, cycloisomerization reactions, and condensation reactions (shown in Figure 1). The synthesis method of isoxazole is now classified as follows by type:
1、通过[3+2]环加成反应合成异恶唑(Cycloaddition):合成异恶唑最常用的方法是氯代肟乙酸酯与炔或烯的1,3-偶极环加成反应。先将芳醛与盐酸羟胺反应得到醛肟,醛肟经氯代丁二酸亚胺(NCS)作用得到氯肟,氯肟在三乙胺作用下得到腈氧化物,随即与炔或烯进1,3-偶极加环加成反应获得目标物异恶唑(图2A)。其合成条件较为温和,制备的异恶唑化合物种类多样,可以直接制备含有氨基、羟基、活泼卤素等活性基团的化合物,而且此种方法在合成方法学上也有重要应用,如发展金属催化、催化剂负载等方法,但是缺点在于底物需要含有末端炔键的化合物,给合成增加一定的限制和难度。朱敏等采用催化量有机高价碘试剂,发展了端基炔烃与醛肟的[3+2]环合反应,合成了一系列3,5-二取代异恶唑类化合物。该反应简单、方便,区域选择性强,实现了无碱条件下的异恶唑合成(如图2B所示)。1. Synthesis of isoxazole (Cycloaddition) by [3+2] cycloaddition reaction: the most commonly used method for synthesizing isoxazole is the 1,3-dipolar cycloaddition reaction of chloroxime acetate with alkynes or alkenes . First, react aromatic aldehyde with hydroxylamine hydrochloride to obtain aldoxime, which is reacted with chlorosuccinimide (NCS) to obtain chloroxime, and chloroxime is reacted with triethylamine to obtain nitrile oxide, and then reacted with alkyne or alkene , 3-dipolar plus cycloaddition reaction to obtain the target isoxazole (Figure 2A). The synthesis conditions are relatively mild, and various types of isoxazole compounds can be prepared. Compounds containing active groups such as amino, hydroxyl, and active halogens can be directly prepared, and this method also has important applications in synthetic methodology, such as the development of metal catalysis, Catalyst loading and other methods, but the disadvantage is that the substrate needs a compound containing terminal alkyne bonds, which adds certain restrictions and difficulties to the synthesis. Zhu Min et al. developed the [3+2] ring closure reaction of terminal alkynes and aldoximes by using catalytic amounts of organic hypervalent iodine reagents, and synthesized a series of 3,5-disubstituted isoxazole compounds. This reaction is simple, convenient, and regioselective, and realizes the synthesis of isoxazole under alkali-free conditions (as shown in Figure 2B).
2、通过环化异构化反应合成异恶唑(Cycloisomerization):通过底物炔酮肟分子内成环也是一种常用的异恶唑合成法。在1970年,Sisido等研究炔酮肟成环时发现,反应体系的酸碱性对成环有明显决定作用(图3A所示)。炔基酮酸酯和盐酸羟胺反应成肟后,若在酸性条件下关环,得到5-取代异恶唑-3-甲酸乙酯(I)若在弱碱性条件下关环,则主要生成异恶唑啉-3-甲酸乙酯(II)。以炔肟形成异恶唑的报道较多,以烯肟形成异恶唑环则比较少见。2009年,兰州大学厍学功课题组利用α,β-不饱和酮酸酯和TsNHOH一锅法合成一系列3,5-二取代的异恶唑化合物,其中以65%的收率合成了3-苯基异恶唑-5-羧酸乙酯(图3B所示)。其可能的成环机理是TsNHOH首先对羰基的α-不饱和烯键发生加成反应,然后脱去苯亚磺酸得到α-羰基肟,该肟脱水形成异恶唑环。2. Synthesis of isoxazole through cycloisomerization (Cycloisomerization): Intramolecular ring formation through the substrate acetylene ketone oxime is also a commonly used synthesis method of isoxazole. In 1970, when Sisido et al. studied the cyclization of acetylene ketone oxime, they found that the acidity and alkalinity of the reaction system had a significant decisive effect on the cyclization (as shown in Figure 3A). After the alkynyl ketoester and hydroxylamine hydrochloride react to form an oxime, if the ring closure is performed under acidic conditions, 5-substituted isoxazole-3-formic acid ethyl ester (I) is obtained if the ring closure is performed under weakly alkaline conditions. Ethyl isoxazoline-3-carboxylate (II). There are many reports on the formation of isoxazoles from alkyne oximes, while the formation of isoxazole rings from enoximes is relatively rare. In 2009, She Xuegong’s research group at Lanzhou University used α, β-unsaturated ketoesters and TsNHOH to synthesize a series of 3,5-disubstituted isoxazole compounds in one pot, and synthesized 3 with a yield of 65%. - Ethyl phenylisoxazole-5-carboxylate (shown in Figure 3B). The possible ring-forming mechanism is that TsNHOH first undergoes addition reaction to the α-unsaturated ethylenic bond of the carbonyl group, and then removes benzenesulfinic acid to obtain α-carbonyl oxime, which is dehydrated to form an isoxazole ring.
此后,在2011年Miyata课题组发展了以苯酚为质子源,Ag+催化下合成了异恶唑(图3C所示)。作者推断催化成环的机理是Ag+与缺电子的炔键结合,从而活化炔键。肟氧原子因连接有供电子基团苄基而使电子云密度增加,肟氧的孤对电子进攻活化的炔键,进而发生加成反应形成异恶唑环,同时肟氧上苄基和Ag+脱离,Ag+在反应中循环催化。但反应收率总体较低,且反应时间较长。Since then, in 2011, Miyata's research group developed the synthesis of isoxazole using phenol as a proton source and Ag + catalysis (shown in Figure 3C). The authors deduce that the mechanism of the catalyzed ring formation is the binding of Ag + to the electron-deficient alkyne bond, thereby activating the alkyne bond. The electron cloud density increases due to the connection of the electron-donating group benzyl to the oxime oxygen atom, and the lone pair of electrons of the oxime oxygen attack the activated alkyne bond, and then an addition reaction occurs to form an isoxazole ring. + detachment, Ag + cyclically catalyzes the reaction. But the overall reaction yield is low, and the reaction time is long.
Zhu课题组在2014年报道了一种钯/银协同催化的新方法(图3D所示)。为了体现方法的适用性,他们将该方法成功应用到药物Valdecoxib和Oxacillin的合成中。然而,贵金属的使用降低了该方法在工业化应用中的可能性。In 2014, Zhu's group reported a new method for palladium/silver synergistic catalysis (shown in Figure 3D). In order to reflect the applicability of the method, they successfully applied the method to the synthesis of drugs Valdecoxib and Oxacillin. However, the use of noble metals reduces the possibility of industrial application of this method.
最近,Chang课题组通过碘介导的氧化性C-O键形成反应由易得的α,β-不饱和肟合成了一系列单、双和三取代(芳基、烷基和/或烯基)的异恶唑类化合物(图3E所示)。该合成方法具有不使用过渡金属、操作简单、反应条件温和、反应时间短,以及底物适用范围广等优点。Recently, Chang's group synthesized a series of mono-, di-, and tri-substituted (aryl, alkyl, and/or alkenyl) oximes from readily available α,β-unsaturated oximes via iodine-mediated oxidative C–O bond formation reactions. Isoxazole compounds (shown in Figure 3E). The synthesis method has the advantages of not using transition metals, simple operation, mild reaction conditions, short reaction time, wide application range of substrates and the like.
3、通过缩合反应合成异恶唑(Condensation):1888年,Claisen等人采用β-酮酯和羟胺反应环化生成了3-羟基异恶唑(图4A所示)。反应可以在非金属条件下实现异恶唑的一锅法合成,但该体系中会生成副产物5-异恶唑酮,降低了主产物的产率。为了弄清楚副反应生成的机理,Cocivera等在1976年通过核磁进行了研究,认为5-异恶唑酮是由热力学不稳定的顺式异构体转变而来的。2000年,Larsen等人通过改进方法,避免副产物5-异恶唑酮的生成(图4B所示)。反应通过将原料进行N,O保护,三步法合成了3-羟基5-甲基异恶唑衍生物。3. Synthesis of isoxazole through condensation reaction (Condensation): In 1888, Claisen et al. used β-ketoester and hydroxylamine to react cyclization to generate 3-hydroxyisoxazole (shown in Figure 4A). The reaction can realize the one-pot synthesis of isoxazole under metal-free conditions, but the by-product 5-isoxazolone will be generated in this system, which reduces the yield of the main product. In order to clarify the mechanism of side reaction generation, Cocivera et al. carried out NMR research in 1976 and believed that 5-isoxazolone was transformed from a thermodynamically unstable cis-isomer. In 2000, Larsen et al. improved the method to avoid the formation of by-product 5-isoxazolone (shown in Figure 4B). In the reaction, 3-hydroxyl 5-methylisoxazole derivatives were synthesized by three-step method through N,O protection of raw materials.
综上所述,自从1888年Claisen等首次发展了异恶唑合成方法以来,研究学者通过新的策略如[3+2]环加成反应,环化异构化反应,缩合反应等方式丰富了异恶唑的合成新方法。In summary, since Claisen et al. first developed the synthesis method of isoxazole in 1888, researchers have enriched the synthesis of isoxazole through new strategies such as [3+2] cycloaddition reaction, cycloisomerization reaction, and condensation reaction. A new method for the synthesis of isoxazoles.
在[3+2]环加成反应策略中,原料醛肟或酮肟存在不易商业化获得,需要提前制备等缺点;此外,在环化异构化反应和缩合反应策略中,需要使用盐酸羟胺试剂,该试剂在大规模使用时存在安全性等制约因素。随着环境问题的日益突出,发展高效、绿色、简便的合成方法学将是未来合成化学的发展方向。In the [3+2] cycloaddition reaction strategy, the raw material aldoxime or ketoxime is not easy to obtain commercially and needs to be prepared in advance; in addition, in the cycloisomerization reaction and condensation reaction strategy, it is necessary to use hydroxylamine hydrochloride Reagents, which have constraints such as safety when used on a large scale. With the increasingly prominent environmental problems, the development of efficient, green and convenient synthetic methodologies will be the development direction of synthetic chemistry in the future.
发明内容Contents of the invention
针对上述问题,本发明提供一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法。In view of the above problems, the present invention provides a method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction.
为实现上述目的,采用以下技术方案:In order to achieve the above purpose, the following technical solutions are adopted:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,将醛、烯烃和亚硝酸酯混合加热反应生成3,5-二取代异恶唑类化合物。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, in which aldehydes, olefins and nitrites are mixed and heated for reaction to generate 3,5-disubstituted isoxazole compounds.
优选地,所述反应在水中进行。Preferably, the reaction is carried out in water.
优选地,所述反应在有机溶剂中进行。Preferably, the reaction is carried out in an organic solvent.
优选地,所述有机溶剂为四氢呋喃、氯苯、丙酮、N,N-二甲基甲酰胺、N-甲基吡咯烷酮、乙腈、二甲亚砜、甲醇或乙醇中的任意一种。Preferably, the organic solvent is any one of tetrahydrofuran, chlorobenzene, acetone, N,N-dimethylformamide, N-methylpyrrolidone, acetonitrile, dimethylsulfoxide, methanol or ethanol.
优选地,向所述反应中加入过硫酸盐作为氧化剂。Preferably, persulfate is added as oxidant to the reaction.
优选地,向所述反应中加入酸性物质或碱性物质。Preferably, an acidic or basic substance is added to the reaction.
优选地,向所述反应中加入硫酸钠。Preferably, sodium sulfate is added to the reaction.
优选地,所述醛选自脂肪族醛、芳香族醛或稠环类醛。所述烯烃选自芳香族烯烃或稠环类烯烃;所述亚硝酸酯选自亚硝酸烷基酯。Preferably, the aldehyde is selected from aliphatic aldehydes, aromatic aldehydes or fused ring aldehydes. The olefin is selected from aromatic olefins or condensed ring olefins; the nitrite is selected from alkyl nitrite.
优选地,所述有机溶剂中含有水,有机溶剂和水的体积比为5:1。Preferably, the organic solvent contains water, and the volume ratio of the organic solvent to water is 5:1.
优选地,所述过硫酸盐为过硫酸钠、过硫酸钾或过硫酸铵中任意一种或几种。Preferably, the persulfate is any one or more of sodium persulfate, potassium persulfate or ammonium persulfate.
优选地,所述酸性物质为甲酸、醋酸、三氟乙酸、盐酸、氢氟酸、三氟化硼乙醚或氟硼酸;所述碱性物质为咪唑、叔丁醇钾、碳酸钠、4-二甲氨基吡啶、醋酸钠、哌嗪、磷酸钾、三乙胺、碳酸氢钠、1,4-二氮杂二环[2.2.2]辛烷、碳酸铯或1,8-二氮杂二环十一碳-7-烯。Preferably, the acidic substance is formic acid, acetic acid, trifluoroacetic acid, hydrochloric acid, hydrofluoric acid, boron trifluoride ether or fluoroboric acid; the basic substance is imidazole, potassium tert-butoxide, sodium carbonate, 4-di Aminopyridine, sodium acetate, piperazine, potassium phosphate, triethylamine, sodium bicarbonate, 1,4-diazabicyclo[2.2.2]octane, cesium carbonate or 1,8-diazabicyclo Undec-7-ene.
优选地,所述醛、烯烃和亚硝酸酯的摩尔比为:1~5:1~10:1~20。Preferably, the molar ratio of the aldehyde, olefin and nitrite is: 1-5:1-10:1-20.
优选地,所述反应的加热温度为20-140℃,反应时间为0.5-24h。Preferably, the heating temperature of the reaction is 20-140°C, and the reaction time is 0.5-24h.
优选地,所述反应的加热温度为100℃,反应时间为8h。Preferably, the heating temperature of the reaction is 100° C., and the reaction time is 8 hours.
本发明具有以下有益效果:1、异恶唑分子中的氮原子来源于亚硝酸酯而不是盐酸羟胺,反应的安全性大大提升;2、所用原料均可商业化购买,不需要提前制备,反应实施起来更加容易,反应操作也更加简便;3、底物的适用范围更广,脂肪烃,芳烃,稠环类等底物均可适用于我们的反应体系;4、反应在酸性环境和碱性环境中均可进行;5、反应在空气条件下可以进行,无需惰性气体保护。The invention has the following beneficial effects: 1. The nitrogen atom in the isoxazole molecule is derived from nitrite instead of hydroxylamine hydrochloride, and the safety of the reaction is greatly improved; 2. The raw materials used can be purchased commercially without preparation in advance, and the reaction It is easier to implement, and the reaction operation is more convenient; 3. The scope of application of the substrate is wider, such as aliphatic hydrocarbons, aromatic hydrocarbons, fused rings and other substrates can be applied to our reaction system; 4. The reaction is in acidic environment and alkaline It can be carried out in any environment; 5. The reaction can be carried out under air conditions without inert gas protection.
本发明的其它特征和优点将在随后的说明书中阐述,并且,部分地从说明书中变得显而易见,或者通过实施本发明而了解。本发明的目的和其他优点可通过在说明书、权利要求书以及附图中所指出的结构来实现和获得。Additional features and advantages of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learned by practice of the invention. The objectives and other advantages of the invention may be realized and attained by the structure pointed out in the written description, claims hereof as well as the appended drawings.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作一简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description These are some embodiments of the present invention. Those skilled in the art can also obtain other drawings based on these drawings without creative work.
图1为现有技术中异恶唑合成方法示意图;Fig. 1 is the synthesizing method schematic diagram of isoxazole in the prior art;
图2为[3+2]环加成法合成异恶唑的方法示意图;Fig. 2 is the schematic diagram of the method for synthesizing isoxazole by [3+2] cycloaddition method;
图3为环化异构化反应合成异恶唑的方法示意图;Fig. 3 is the synthesizing method schematic diagram of isoxazole by cycloisomerization reaction;
图4为缩合反应合成异恶唑的方法示意图;Fig. 4 is the schematic diagram of the method for synthesizing isoxazole by condensation reaction;
图5为本发明实施例1中生成物3,5-二苯基异恶唑的反应式示意图;Figure 5 is a schematic diagram of the reaction formula of the
图6为示例性给出本发明改变底物所得到的不同产物;Figure 6 exemplifies the different products obtained by changing the substrate of the present invention;
图7为本发明反应机理示意图;Fig. 7 is a schematic diagram of the reaction mechanism of the present invention;
图8为本发明各实施例反应条件和产率结果图。Fig. 8 is a graph showing the reaction conditions and yield results of various embodiments of the present invention.
具体实施方式Detailed ways
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地说明,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
实施例1:Example 1:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,采用0.5mmol苯乙烯、0.25mmol对溴苯甲醛,0.5mmol亚硝酸叔丁酯(TBN),在0.6mL溶剂水中100℃下加热下反应8小时,柱色谱分离得到白色透明晶体3aa,产率为5%。A method for synthesizing 3,5-disubstituted isoxazoles based on a three-component reaction, using 0.5mmol styrene, 0.25mmol p-bromobenzaldehyde, 0.5mmol tert-butyl nitrite (TBN), in 0.6mL solvent The reaction was carried out under heating in water at 100° C. for 8 hours, and the white transparent crystal 3aa was obtained by column chromatography with a yield of 5%.
实施例2:Example 2:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例1的区别在于,所用溶剂为DMF,产率为15%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 1 is that the solvent used is DMF, and the yield is 15%.
实施例3:Example 3:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例1的区别在于,所用溶剂为DMF和水的混合溶液,DMF和水的比例为5:1,产率为35%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 1 is that the solvent used is a mixed solution of DMF and water, and the ratio of DMF and water is 5:1, The yield is 35%.
实施例4:Example 4:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例3的区别在于,反应时还添加0.125mmolK2S2O8作为氧化剂,产率为47%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 3 is that 0.125 mmol K 2 S 2 O 8 is added as an oxidant during the reaction, and the yield is 47%.
实施例5:Example 5:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例4的区别在于,反应时还添加0.625mmol醋酸,产率为51%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 4 is that 0.625 mmol of acetic acid is added during the reaction, and the yield is 51%.
实施例6:Embodiment 6:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例5的区别在于,反应时还添加0.25mmol硫酸钠,产率为58%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 5 is that 0.25 mmol of sodium sulfate is also added during the reaction, and the yield is 58%.
实施例7:Embodiment 7:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例6的区别在于,反应时添加0.5mmol硫酸钠,产率为61%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 6 is that 0.5 mmol of sodium sulfate is added during the reaction, and the yield is 61%.
实施例8:Embodiment 8:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例6的区别在于,反应温度为80℃,产率为52%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 6 is that the reaction temperature is 80° C., and the yield is 52%.
实施例9:Embodiment 9:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例6的区别在于,反应温度为110℃,产率为61%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 6 is that the reaction temperature is 110° C., and the yield is 61%.
实施例10:Example 10:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例6的区别在于,反应温度为120℃,产率为40%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 6 is that the reaction temperature is 120° C., and the yield is 40%.
实施例11:Example 11:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例6的区别在于,采用的苯乙烯为0.25mmol,产率为22%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 6 is that 0.25 mmol of styrene is used, and the yield is 22%.
实施例12:Example 12:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,与实施例6的区别在于,采用的苯乙烯为0.75mmol,产率为71%。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction, the difference from Example 6 is that 0.75 mmol of styrene is used, and the yield is 71%.
实施例13:Example 13:
一种基于三组分反应合成3,5-二取代异恶唑类化合物的方法,首先采用2mmol苯乙烯、1mmol苯甲醛,2mmol亚硝酸叔丁酯,在2mL溶剂DMF中30℃加热下反应3小时,柱色谱分离得到白色透明晶体4a,产率为5%。将所制备的化合物进行核磁分析,结果显示4a为3,5-二苯基异恶唑,反应式如图5所示。以上各实施例反应条件和产率结果见图8。A method for synthesizing 3,5-disubstituted isoxazole compounds based on a three-component reaction. First, 2mmol styrene, 1mmol benzaldehyde, and 2mmol tert-butyl nitrite are used to react in 2mL solvent DMF at 30°C for 3 Hours, column chromatography gave white
进一步地,本发明所述方法不仅限于上述反应底物,脂肪醛,芳基醛基和稠环类的醛等醛类底物均适用于此反应,如图6所示,对应反应物1和反应物2采用不同的底物,分别得到不同的生成物4,示例性地,如化合物4a、4b......4u或5a、5b......5f等。Further, the method of the present invention is not limited to the above-mentioned reaction substrates, and aldehyde substrates such as aliphatic aldehydes, aryl aldehyde groups and fused ring aldehydes are suitable for this reaction, as shown in Figure 6, corresponding
本发明所用方法经过以下反应路线,如图7所示:即采用醛A和烯烃B以及亚硝酸酯E做反应物,在反应体系中,醛A在氧化剂作用下产生的醛自由基C对烯烃进行加成,生成自由基D。此时,自由基D与由亚硝酸酯E受热产生的亚硝基自由基F发生自由基偶联反应,可生成化合物G,并快速异构化成1,3-二羰基酮肟中间体H,随后发生分子内的关环反应,生成化合物I,通过失去1分子水生成目标物异恶唑类化合物J。结合图6所示,该反应体系中,醛类底物如脂肪族醛环己甲醛(反应后生成产物4u),芳香族醛苯甲醛(反应后生成产物4a),杂环类醛4-吡啶甲醛(反应后生成产物4r)等均可适用,烯烃类底物如脂肪族烯烃1-己烯(反应后生成产物5f),芳香族烯烃4-溴苯乙烯(反应后生成产物5a),稠环类烯烃2-萘烯(反应后生成产物5d)等均可适用;亚硝酸酯类底物如亚硝酸异丁酯、亚硝酸正丁酯、亚硝酸异戊酯等均可适用;反应在酸性环境和碱性环境中均可进行。The method used in the present invention passes through the following reaction route, as shown in Figure 7: promptly adopt aldehyde A and olefin B and nitrite E to make reactant, in reaction system, the aldehyde free radical C that aldehyde A produces under the action of oxidizing agent is to olefin Addition is performed to generate free radical D. At this time, the radical coupling reaction between the free radical D and the nitroso radical F generated by the heating of the nitrite E can generate compound G, which is rapidly isomerized into 1,3-dicarbonyl ketoxime intermediate H, Subsequently, an intramolecular ring-closing reaction occurs to generate compound I, and the target isoxazole compound J is generated by losing one molecule of water. As shown in Figure 6, in this reaction system, aldehyde substrates such as aliphatic aldehyde cyclohexanaldehyde (reaction produces
综上所述,本发明中异恶唑分子中的氮原子来源于TBN分子而不是盐酸羟胺,采用盐酸羟胺做来源,通常需提前通过底物醛或酮反应制备醛肟或酮肟,操作繁琐,且盐酸羟胺在大规模反应时存在安全性问题。采用TBN做原料时,原料无需提前准备,可一锅法完成,安全性相对盐酸羟胺较好。To sum up, the nitrogen atom in the isoxazole molecule in the present invention is derived from TBN molecule instead of hydroxylamine hydrochloride. Hydroxylamine hydrochloride is used as the source. Usually, it is necessary to prepare aldoxime or ketoxime by reacting substrate aldehyde or ketone in advance, and the operation is cumbersome. , and hydroxylamine hydrochloride has safety problems during large-scale reactions. When TBN is used as the raw material, the raw material does not need to be prepared in advance, and it can be completed in one pot, and the safety is better than that of hydroxylamine hydrochloride.
尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that: they can still modify the technical solutions described in the aforementioned embodiments, or perform equivalent replacements for some of the technical features; and these The modification or replacement does not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the various embodiments of the present invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110994157.0A CN113698359B (en) | 2021-08-27 | 2021-08-27 | Method for synthesizing 3,5-disubstituted isoxazole compound based on three-component reaction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110994157.0A CN113698359B (en) | 2021-08-27 | 2021-08-27 | Method for synthesizing 3,5-disubstituted isoxazole compound based on three-component reaction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113698359A CN113698359A (en) | 2021-11-26 |
| CN113698359B true CN113698359B (en) | 2023-04-07 |
Family
ID=78655798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110994157.0A Active CN113698359B (en) | 2021-08-27 | 2021-08-27 | Method for synthesizing 3,5-disubstituted isoxazole compound based on three-component reaction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113698359B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7169797B2 (en) * | 2003-02-14 | 2007-01-30 | Abbott Laboratories | Protein-tyrosine phosphatase inhibitors and uses thereof |
| CN113149924B (en) * | 2021-03-29 | 2023-11-03 | 苏州大学 | Simple preparation method of isoxazoline |
-
2021
- 2021-08-27 CN CN202110994157.0A patent/CN113698359B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN113698359A (en) | 2021-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | TBHP/I 2-promoted oxidative coupling of acetophenones with amines at room temperature under metal-free and solvent-free conditions for the synthesis of α-ketoamides | |
| JP4999850B2 (en) | Ruthenium-catalyzed cycloaddition of alkynes and organic azides | |
| Yu et al. | Palladium-catalyzed desulfitative arylation of azoles with arylsulfonyl hydrazides | |
| Jiang et al. | Palladium-catalyzed primary amine-directed regioselective mono-and di-alkynylation of biaryl-2-amines | |
| Zhang et al. | A novel and metal-free approach towards α-ketoamides using a TBHP/I 2-promoted tandem reaction of amines with β-diketones via C–C bond cleavage | |
| CN110483400B (en) | A kind of preparation method of pyrazole derivative | |
| CN113698359B (en) | Method for synthesizing 3,5-disubstituted isoxazole compound based on three-component reaction | |
| Wang et al. | Silver-catalyzed intermolecular amination of fluoroarenes | |
| CN110003011B (en) | A kind of preparation method of nitroalkene derivative with nitrate as nitro source | |
| CN116905020A (en) | Method for synthesizing 1, 3-fluoroamine product by electrochemical mode | |
| CN113024470B (en) | A kind of 4-perfluoroalkyl substituted pyrimidine compound and its preparation method and application | |
| Wu et al. | Cu (OAc) 2-catalyzed three-component cycloaddition of malonates, nitrosoarenes and alkenes: access to isoxazolidines | |
| CN107382886B (en) | Method for constructing N-2-aryl substituted-1, 2, 3-triazole | |
| Yang et al. | Photoinduced radical cascade cyclization of acetylenic acid esters with oxime esters to access cyanalkylated coumarins | |
| Bhat et al. | Stereoselective copper-catalyzed heteroarene C–H functionalization/Michael-type annulation cascade with α-diazocarbonyls | |
| CN115093368B (en) | Method for preparing quinoline-2,4-dione derivatives by copper-catalyzed cyclization/oxidative cleavage of α-bromocarbonylalkyne | |
| CN111393437A (en) | Trisubstituted indolizine compound and preparation method thereof | |
| Ji et al. | Copper-catalyzed cyclization reaction: synthesis of trifluoromethylated indolinyl ketones | |
| Yao et al. | Synthesis of pyrazolo [5, 1-a] isoquinolines via silver (i)–rhodium (i) cooperative catalysis in the reaction of N′-(2-alkynylbenzylidene) hydrazide with cycloprop-2-ene-1, 1-dicarboxylate | |
| CN108586375B (en) | A green method for the synthesis of 2-substituted benzoxazole compounds by biocatalytic oxidative cyclization | |
| Bensalah et al. | Palladium (ii)/N-heterocyclic carbene (NHC) catalyzed direct C–H arylation of heteroarenes with different aryl bromides and chlorides | |
| CN112225701A (en) | Synthesis method of N-vinyl azole compound | |
| CN109134343A (en) | A kind of new method of the position indoles C-2 alkenyl | |
| CN116695145A (en) | A kind of isoxazole derivative and its electrochemical preparation method | |
| CN119710736B (en) | A method for synthesizing 1,3-arylamine compounds by electrocatalysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |